Platform Trials — Beware the Noncomparable Control Group
Dodd, Lori E, Freidlin, Boris, Korn, Edward L
Published in The New England journal of medicine (22.04.2021)
Published in The New England journal of medicine (22.04.2021)
Get full text
Journal Article
Adaptive Clinical Trials: Advantages and Disadvantages of Various Adaptive Design Elements
Korn, Edward L, Freidlin, Boris
Published in JNCI : Journal of the National Cancer Institute (01.06.2017)
Published in JNCI : Journal of the National Cancer Institute (01.06.2017)
Get full text
Journal Article
Avoiding Delays in Reporting Time-to-Event Randomized Trials: Calendar Backstops and Other Approaches
Othus, Megan, Freidlin, Boris, Korn, Edward L
Published in Journal of clinical oncology (17.05.2024)
Published in Journal of clinical oncology (17.05.2024)
Get full text
Journal Article
A Problematic Biomarker Trial Design
Freidlin, Boris, Korn, Edward L
Published in JNCI : Journal of the National Cancer Institute (07.02.2022)
Published in JNCI : Journal of the National Cancer Institute (07.02.2022)
Get full text
Journal Article
Dose optimization during drug development: whether and when to optimize
Korn, Edward L, Moscow, Jeffrey A, Freidlin, Boris
Published in JNCI : Journal of the National Cancer Institute (08.05.2023)
Published in JNCI : Journal of the National Cancer Institute (08.05.2023)
Get full text
Journal Article
Backfilling Patients in Phase I Dose-Escalation Trials Using Bayesian Optimal Interval Design (BOIN)
Zhao, Yixuan, Yuan, Ying, Korn, Edward L, Freidlin, Boris
Published in Clinical cancer research (16.02.2024)
Published in Clinical cancer research (16.02.2024)
Get full text
Journal Article
Polymerization pathway of mammalian nonmuscle myosin 2s
Liu, Xiong, Shu, Shi, Korn, Edward D.
Published in Proceedings of the National Academy of Sciences - PNAS (24.07.2018)
Published in Proceedings of the National Academy of Sciences - PNAS (24.07.2018)
Get full text
Journal Article